Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

RUA GOLD Engages ICP Securities Inc. for Automated...

November 3, 2025

Sun Summit Minerals: Advancing District-scale Gold and Copper...

July 4, 2025

Bold Ventures Closes $776,800 Non-Brokered Private Placement

January 3, 2026

E-Power Resources Inc. Announces Tetepisca Flake Graphite Property...

November 21, 2025

Uranium Price Update: Q2 2025 in Review

July 30, 2025

Electric Royalties Announces Interest Conversion Under Convertible Credit...

December 31, 2025

Bold Ventures Announces Prospecting and Sampling Results and...

September 12, 2025

Drilling the Manindi Vanadium-Titanium-Magnetite Discovery

November 6, 2025

Lac Carheil MRE to Benefit from Exceptional Assay...

July 18, 2025

Lode Gold Engages Strategic Advisors to Advance Development...

June 25, 2025